• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-淀粉样蛋白和α-突触核蛋白原纤维前体中间体的体外制备。

In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.

作者信息

Lashuel Hilal A, Grillo-Bosch Dolors

机构信息

Center for Neurologic Diseases, Brigham and Women's Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA.

出版信息

Methods Mol Biol. 2005;299:19-33. doi: 10.1385/1-59259-874-9:019.

DOI:10.1385/1-59259-874-9:019
PMID:15980593
Abstract

Elucidating the structural properties of early intermediates (protofibrils) on the fibril formation pathway of Abeta and alpha-synuclein, the structural relationship among the different intermediates and their relationship to the structure of the amyloid fibrils is critical for understanding the roles of amyloid fibril formation in the pathogenesis of Alzheimer's and Parkinson's diseases. In this chapter we discuss several methods, developed by different laboratories, that enable the preparation and stabilization of amyloid-beta and alpha-synuclein protofibrillar species of defined morphologies for biochemical, biophysical and toxicity studies.

摘要

阐明β-淀粉样蛋白(Aβ)和α-突触核蛋白在纤维形成途径中早期中间体(原纤维)的结构特性、不同中间体之间的结构关系以及它们与淀粉样纤维结构的关系,对于理解淀粉样纤维形成在阿尔茨海默病和帕金森病发病机制中的作用至关重要。在本章中,我们将讨论不同实验室开发的几种方法,这些方法能够制备和稳定具有特定形态的β-淀粉样蛋白和α-突触核蛋白原纤维物种,用于生化、生物物理和毒性研究。

相似文献

1
In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.β-淀粉样蛋白和α-突触核蛋白原纤维前体中间体的体外制备。
Methods Mol Biol. 2005;299:19-33. doi: 10.1385/1-59259-874-9:019.
2
ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures.与家族性英国痴呆症相关的ABri肽形成环状和环形原纤维结构。
Amyloid. 2004 Mar;11(1):10-3. doi: 10.1080/13506120410001667872.
3
Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease.多巴胺和左旋多巴可解聚淀粉样纤维:对帕金森病和阿尔茨海默病的启示。
FASEB J. 2004 Jun;18(9):962-4. doi: 10.1096/fj.03-0770fje. Epub 2004 Apr 1.
4
Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.通过压力使α-突触核蛋白和转甲状腺素蛋白的淀粉样原纤维解离,揭示了它们的可逆性质以及水排斥腔的形成。
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9831-6. doi: 10.1073/pnas.1734009100. Epub 2003 Aug 4.
5
Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation.工程化的α-突触核蛋白可防止野生型和家族性帕金森病蛋白变体原纤维形成。
Biochem Biophys Res Commun. 2005 Sep 23;335(2):432-6. doi: 10.1016/j.bbrc.2005.07.100.
6
beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.β-淀粉样肽在一个将阿尔茨海默病和帕金森病联系起来的转基因小鼠模型中增强α-突触核蛋白的积累和神经元缺陷。
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12245-50. doi: 10.1073/pnas.211412398. Epub 2001 Sep 25.
7
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.由α-突触核蛋白以及与帕金森病相关的两种突变形式在体外形成的原纤维是典型的淀粉样蛋白。
Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r.
8
Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.与阿尔茨海默病、帕金森病及其他神经退行性疾病相关的聚集蛋白产生活性氧物种。
Curr Top Med Chem. 2001 Dec;1(6):507-17. doi: 10.2174/1568026013394822.
9
Neurodegenerative disease: amyloid pores from pathogenic mutations.神经退行性疾病:致病性突变产生的淀粉样蛋白孔道
Nature. 2002 Jul 18;418(6895):291. doi: 10.1038/418291a.
10
Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.用分子模拟深入了解阿尔茨海默病和帕金森病的分子机制:了解与病理学相关的无序蛋白质中人工和病理性错义突变的作用。
Int J Mol Sci. 2018 Jan 24;19(2):336. doi: 10.3390/ijms19020336.

引用本文的文献

1
Inflammatory mechanisms in neurodegeneration.神经退行性变中的炎症机制。
J Neurochem. 2019 Jun;149(5):562-581. doi: 10.1111/jnc.14674. Epub 2019 Mar 27.
2
Structural characteristics and membrane interactions of tandem α-synuclein oligomers.串联 α-突触核蛋白寡聚物的结构特征和膜相互作用。
Sci Rep. 2018 Apr 30;8(1):6755. doi: 10.1038/s41598-018-25133-0.
3
The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer.Aβ42二聚体的聚集途径和产物与Aβ42单体的不同。
Biochemistry. 2016 Nov 8;55(44):6150-6161. doi: 10.1021/acs.biochem.6b00453. Epub 2016 Oct 26.
4
Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.在Aβ42/Aβ40混合物中,Aβ40对Aβ42原纤维形成有微妙影响,但程度低于Aβ42浓度。
Arch Biochem Biophys. 2016 May 1;597:1-11. doi: 10.1016/j.abb.2016.03.017. Epub 2016 Mar 21.
5
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.帕金森病中神经黑色素与α-突触核蛋白之间的相互作用
Biomolecules. 2015 Jun 5;5(2):1122-42. doi: 10.3390/biom5021122.
6
The slowly aggregating salmon Calcitonin: a useful tool for the study of the amyloid oligomers structure and activity.缓慢聚集的鲑鱼降钙素:研究淀粉样寡聚体结构和活性的有用工具。
Int J Mol Sci. 2011;12(12):9277-95. doi: 10.3390/ijms12129277. Epub 2011 Dec 13.
7
Drug targets from genetics: α-synuclein.从遗传学角度看药物靶点:α-突触核蛋白。
CNS Neurol Disord Drug Targets. 2011 Sep 1;10(6):712-23. doi: 10.2174/187152711797247867.
8
Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line.淀粉样β蛋白(1-42)纤维状前体最适合在THP-1人单核细胞系中诱导肿瘤坏死因子-α的产生。
Biochemistry. 2009 Sep 29;48(38):9011-21. doi: 10.1021/bi9003777.
9
Molecular pathology of Lewy body diseases.路易体病的分子病理学。
Int J Mol Sci. 2009 Mar;10(3):724-45. doi: 10.3390/ijms10030724. Epub 2009 Feb 26.
10
Detecting morphologically distinct oligomeric forms of alpha-synuclein.检测α-突触核蛋白形态上不同的寡聚体形式。
J Biol Chem. 2009 Apr 24;284(17):11048-58. doi: 10.1074/jbc.M806559200. Epub 2009 Jan 13.